title: Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis.
authors.affiliation: Department of Cardiothoracic Surgery and Medicine, Stanford University, California, USA.
authors.forename: H
authors.initials: H
authors.lastname: Reichenspurner
authors.forename: P
authors.initials: P
authors.lastname: Gamberg
authors.forename: M
authors.initials: M
authors.lastname: Nitschke
authors.forename: H
authors.initials: H
authors.lastname: Valantine
authors.forename: S
authors.initials: S
authors.lastname: Hunt
authors.forename: P E
authors.initials: PE
authors.lastname: Oyer
authors.forename: B A
authors.initials: BA
authors.lastname: Reitz
mesh_terms: D000328:Adult; D000336:Aerosols; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001228:Aspergillosis / Q000453:epidemiology / Q000517:prevention & control*; D002177:Candidiasis / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D005500:Follow-Up Studies; D016027:Heart Transplantation; D016041:Heart-Lung Transplantation; D006801:Humans; D015994:Incidence; D016040:Lung Transplantation; D008297:Male; D011183:Postoperative Complications; D013997:Time Factors
chemical_list: D000336:Aerosols; D000935:Antifungal Agents; D000666:Amphotericin B